Chemomab Therapeutics Ltd. Cash and Restricted Cash
Chemomab Therapeutics Ltd. (CMMB) had Cash and Restricted Cash of $7.56 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-23
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.56M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.60M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.15M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.11M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $7.56M 20-F · filed 2026-03-23 | |
| 2025-06-30 | $5.60M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $6.15M 20-F · filed 2026-03-23 | |
| 2024-06-30 | $5.11M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $9.37M 20-F · filed 2026-03-23 | |
| 2023-06-30 | $10.46M 6-K · filed 2024-08-21 | |
| 2023-03-31 | $20.84M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $13.60M 20-F · filed 2026-03-23 | |
| 2022-09-30 | $10.82M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $9.96M 6-K · filed 2023-08-14 | |
| 2022-03-31 | $13.91M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $15.24M 20-F · filed 2025-04-04 | |
| 2021-09-30 | $37.80M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $45.45M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $58.23M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $11.73M 20-F · filed 2024-03-28 | $5.39M 10-K · filed 2021-03-09 |
| 2020-09-30 | $12.73M 10-Q · filed 2021-11-12 | $6.77M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $13.08M 10-Q · filed 2021-08-13 | $8.82M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $10.84M 10-Q · filed 2021-05-13 | $14.13M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $12.28M 10-K · filed 2022-03-30 | $17.70M 10-K · filed 2020-03-17 |
| 2019-09-30 | $23.37M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $27.13M 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $32.26M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $7.64M 10-K · filed 2021-03-09 | |
| 2017-12-31 | $1.45M 10-K · filed 2020-03-17 |